Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. [electronic resource]
Producer: 20010809Description: 317-24 p. digitalISSN:- 1524-4539
- Animals
- Animals, Genetically Modified
- Cardiomegaly -- complications
- Cardiomyopathy, Hypertrophic -- complications
- Cell Line
- Disease Models, Animal
- Echocardiography
- Echocardiography, Doppler
- Endomyocardial Fibrosis -- complications
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Hypolipidemic Agents -- administration & dosage
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3
- Mitogen-Activated Protein Kinases -- metabolism
- Mutation
- Myocardium -- metabolism
- Myosin Heavy Chains -- genetics
- Phenotype
- Rabbits
- Remission Induction
- Simvastatin -- administration & dosage
- Ventricular Function, Left -- drug effects
- ras Proteins -- metabolism
- rhoA GTP-Binding Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.